Flschungen und nicht zugelassene Nachahmerprodukte mit GLP-1- Wirkstoffen Zu Beginn des ffentlichen Interesses an GLP-1-Prparaten kam es wiederholt zu Fllen von Produktflschungen durch Etikettentausch
In a 4-year CV outcomes trial (Trial 7), cholelithiasis was reported in 1.1% of patients treated with semaglutide tablets 14 mg and in 0.9% of placebo-treated patients
This study seeks to understand the applicability of recently-developed Australian recommendations for PROMs inclusion, while also gaining insights into current practices, barriers, and enablers to PROMs implementation in the international clinical registries
Speak with a qualified mental health practitioner for additional assistance if needed
Furthermore, the role of GLP-1R agonists in the treatment of neurodegenerative diseases such as Alzheimers disease (AD) and Parkinsons disease (PD) is being actively explored (Siddeeque et al., 2024)
If the specific medication your doctor recommends is not on your health plans formulary, you and your doctor can file an appeal, asking the plan to cover the drug anyway